Listed

Processa Pharmaceuticals, Inc.

PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31

Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Processa Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2020-07-1717:25 ETS-1/ARegistration statement, amended0001493152-20-013568
2020-06-0107:01 ET8-K1.01 Entry into a material agreement0001493152-20-010206
2020-05-2822:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-009985
2020-05-1513:23 ET10-QQuarterly reportPeriod 2020-03-310001493152-20-009002
2020-03-3016:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-005196
2020-03-1709:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-004116
2020-03-0617:17 ET10-KAnnual reportPeriod 2019-12-310001493152-20-003534
2020-03-0509:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-20-003415
2020-02-2509:30 ET8-K8.01 Other events0001493152-20-002918
2020-02-1309:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-002171
2020-01-1414:20 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-20-000565
2019-12-2016:20 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-019526
2019-12-1317:32 ETS-1Registration statement0001493152-19-019202
2019-11-1411:45 ET10-QQuarterly reportPeriod 2019-09-300001493152-19-017267
2019-10-2307:20 ET8-K7.01 Regulation FD disclosure0001493152-19-015853
2019-10-0317:47 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-19-014907
2019-09-0417:19 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-19-013686
2019-08-1412:14 ET10-QQuarterly reportPeriod 2019-06-300001493152-19-012368
2019-06-2119:51 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-19-009519
2019-06-0709:00 ET8-K7.01 Regulation FD disclosure0001493152-19-008837
2019-05-1413:08 ET10-QQuarterly reportPeriod 2019-03-310001493152-19-007021
2019-04-2617:02 ETDEF 14AProxy statementPeriod 2019-04-260001493152-19-006019
2019-04-0821:40 ET10-K/AAnnual report, amendedPeriod 2018-12-310001493152-19-004990
2019-03-2817:25 ET10-KAnnual reportPeriod 2018-12-310001493152-19-004137
2019-03-1307:49 ET8-K7.01 Regulation FD disclosure0001493152-19-003235
2019-02-2506:02 ET8-K7.01 Regulation FD disclosure0001493152-19-002474
2019-01-0909:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-000348
2018-12-0609:00 ET8-K3.01 Delisting notice; 8.01 Other events0001493152-18-017091
2018-11-1421:37 ET10-QQuarterly reportPeriod 2018-09-300001493152-18-015821
2018-10-3016:19 ETS-1/ARegistration statement, amended0001493152-18-014994
2018-10-0917:32 ETS-1/ARegistration statement, amended0001493152-18-014282
2018-10-0320:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-18-014019
2018-09-1416:13 ETS-1/ARegistration statement, amended0001493152-18-013266
2018-09-1009:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-18-013033
2018-08-1417:29 ET10-QQuarterly reportPeriod 2018-06-300001493152-18-011912
2018-07-3016:22 ETS-1Registration statement0001493152-18-010649
2018-07-0617:29 ET8-K1.01 Entry into a material agreement0001493152-18-009782
2018-06-0409:15 ET8-K7.01 Regulation FD disclosure0001493152-18-008158
2018-06-0108:26 ET8-K1.01 Entry into a material agreement0001493152-18-008107
2018-05-2112:42 ET10-QQuarterly reportPeriod 2018-03-310001493152-18-007514
2018-04-1714:02 ET10-K/AAnnual report, amendedPeriod 2017-12-310001493152-18-005289
2018-04-1616:58 ET10-KAnnual reportPeriod 2017-12-310001493152-18-005248
2018-03-3021:06 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001493152-18-004197
2018-01-2410:57 ET8-K/A9.01 Financial statements and exhibits0001493152-18-000954
2017-12-1517:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001393905-17-000400
2017-12-0619:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-17-000391
2017-11-2015:33 ET10-QQuarterly reportPeriod 2017-09-300001393905-17-000369
2017-11-0215:53 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001393905-17-000335
2017-10-3017:27 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001393905-17-000333
2017-10-2014:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001393905-17-000325

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.